← Oncology Approval Tracker

FDA DECISION ·

Opdivo + Yervoy

nivolumab + ipilimumab · Bristol Myers Squibb

FDA approvalNew or expanded indicationHepatocellular carcinoma
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

As first-line treatment for adults with unresectable or metastatic hepatocellular carcinoma.

LAMPGEN ANALYSIS

Why it matters

CheckMate 9DW supported moving combined PD-1 and CTLA-4 blockade into the first-line liver cancer setting.

What research teams should watch

Prespecify how sites will document baseline liver function and evaluate changes that could reflect either treatment toxicity or underlying liver disease.

PRIMARY RECORDS

Sources